Filing Alert: Clearside Biomedical, Inc. Chapter 11

Clearside Biomedical, Inc., an Alpharetta, GA-based clinical-stage biopharmaceutical company focused on therapies for serious eye diseases, filed for Chapter 11 protection on Nov. 23 in the U.S. Bankruptcy Court for the District of Delaware.

The company reports $8.8 million in assets and $64.1 million in liabilities. The filing indicates that there will be funds available for distribution to unsecured creditors. The case number is 25-12109.

---

Key Parties

Counsel:

• Daniel J. DeFranceschi
  Richards, Layton & Finger, P.A.
  Email: defranceschi@rlf.com

Lead Bankruptcy Counsel:

• Cooley LLP

Financial Advisor:

• Berkeley Research Group

Signatories:

• George Lasezkay – President and Chief Executive Officer

Claims Agent:

• Epiq Corporate Restructuring, LLC